首页 > 最新文献

Journal of Orthopaedic Translation最新文献

英文 中文
Macropinocytosis fuels osteoclast differentiation in bone-related diseases 巨噬细胞增多症促进骨相关疾病的破骨细胞分化
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-30 DOI: 10.1016/j.jot.2025.09.005
Mengqin Gu , Linyu Xue , Shidian Ran , Ying Yuan , Qiming Zhai , Hongmei Zhang , Hua Zhang , Ping Ji

Objective

Multinucleated osteoclasts are the principal specialised cells responsible for bone resorption, but osteoclastogenesis, the formation of osteoclasts, entails substantial nutrient and bioenergetic demands. Macropinocytosis is an efficient pathway for nutrient scavenging in metabolically active cells; however, the interplay among metabolic state, osteoclast differentiation and macropinocytosis in bone-related diseases remains poorly understood.

Methods

In this study, osteoclast differentiation was induced using murine bone marrow-derived macrophages and RAW 264.7 cells to investigate the role of macropinocytosis in metabolic regulation. Lipopolysaccharide (LPS) was applied to mimic inflammatory conditions in vitro to assess the influence of macropinocytosis on both metabolic profiles and inflammation-associated osteoclastogenesis. Additionally, ligature-induced periodontitis and ovariectomy (OVX)-induced bone loss models in mice were employed to evaluate the in vivo impact of macropinocytosis on bone resorption.

Results

Enhanced macropinocytosis promoted osteoclast formation, with LPS further accelerating differentiation and increasing macropinocytic activity. This upregulation helped to meet the energy requirements of osteoclastogenesis via oxidative phosphorylation and glycolysis. Inhibition of macropinocytosis with (N-ethyl-N-isopropyl) amiloride (EIPA) reduced energy production and suppressed osteoclast differentiation. Elevated macropinocytosis was also observed in the periodontitis and OVX models, and its inhibition led to early, dose-dependent restoration of bone mass.

Conclusion

Macropinocytosis provides a critical energy source for osteoclast differentiation. Targeting this pathway with EIPA represents a promising therapeutic approach for bone-related diseases.

The translational potential of this article

As a bulk endocytic process, macropinocytosis offers a novel therapeutic target for bone-related diseases. The efficacy of EIPA in suppressing osteoclastogenesis and bone resorption suggests its potential as a clinical intervention drug.
多核破骨细胞是骨吸收的主要特化细胞,但破骨细胞的形成需要大量的营养和生物能量。巨饮作用是代谢活跃细胞清除营养物质的有效途径;然而,在骨相关疾病中,代谢状态、破骨细胞分化和巨噬细胞增多之间的相互作用仍然知之甚少。方法采用小鼠骨髓源性巨噬细胞和RAW 264.7细胞诱导破骨细胞分化,探讨巨噬细胞在代谢调节中的作用。应用脂多糖(LPS)在体外模拟炎症条件,以评估巨噬细胞增多症对代谢谱和炎症相关破骨细胞生成的影响。此外,采用结扎性牙周炎和卵巢切除术(OVX)诱导的小鼠骨丢失模型来评估巨噬细胞增多症对骨吸收的体内影响。结果巨噬细胞增多促进破骨细胞形成,LPS进一步加速破骨细胞分化,增加巨噬细胞活性。这种上调有助于通过氧化磷酸化和糖酵解来满足破骨细胞生成的能量需求。(n -乙基- n -异丙基)酰胺(EIPA)抑制巨噬细胞增多症可减少能量产生并抑制破骨细胞分化。在牙周炎和OVX模型中也观察到巨噬细胞增多,其抑制导致骨量的早期剂量依赖性恢复。结论巨噬细胞作用是破骨细胞分化的重要能量来源。用EIPA靶向这一途径是治疗骨相关疾病的一种很有前途的方法。巨噬细胞的大量内吞过程为骨相关疾病的治疗提供了新的靶点。EIPA在抑制破骨细胞发生和骨吸收方面的作用提示其作为临床干预药物的潜力。
{"title":"Macropinocytosis fuels osteoclast differentiation in bone-related diseases","authors":"Mengqin Gu ,&nbsp;Linyu Xue ,&nbsp;Shidian Ran ,&nbsp;Ying Yuan ,&nbsp;Qiming Zhai ,&nbsp;Hongmei Zhang ,&nbsp;Hua Zhang ,&nbsp;Ping Ji","doi":"10.1016/j.jot.2025.09.005","DOIUrl":"10.1016/j.jot.2025.09.005","url":null,"abstract":"<div><h3>Objective</h3><div>Multinucleated osteoclasts are the principal specialised cells responsible for bone resorption, but osteoclastogenesis, the formation of osteoclasts, entails substantial nutrient and bioenergetic demands. Macropinocytosis is an efficient pathway for nutrient scavenging in metabolically active cells; however, the interplay among metabolic state, osteoclast differentiation and macropinocytosis in bone-related diseases remains poorly understood.</div></div><div><h3>Methods</h3><div>In this study, osteoclast differentiation was induced using murine bone marrow-derived macrophages and RAW 264.7 cells to investigate the role of macropinocytosis in metabolic regulation. Lipopolysaccharide (LPS) was applied to mimic inflammatory conditions in vitro to assess the influence of macropinocytosis on both metabolic profiles and inflammation-associated osteoclastogenesis. Additionally, ligature-induced periodontitis and ovariectomy (OVX)-induced bone loss models in mice were employed to evaluate the in vivo impact of macropinocytosis on bone resorption.</div></div><div><h3>Results</h3><div>Enhanced macropinocytosis promoted osteoclast formation, with LPS further accelerating differentiation and increasing macropinocytic activity. This upregulation helped to meet the energy requirements of osteoclastogenesis via oxidative phosphorylation and glycolysis. Inhibition of macropinocytosis with (N-ethyl-N-isopropyl) amiloride (EIPA) reduced energy production and suppressed osteoclast differentiation. Elevated macropinocytosis was also observed in the periodontitis and OVX models, and its inhibition led to early, dose-dependent restoration of bone mass.</div></div><div><h3>Conclusion</h3><div>Macropinocytosis provides a critical energy source for osteoclast differentiation. Targeting this pathway with EIPA represents a promising therapeutic approach for bone-related diseases.</div></div><div><h3>The translational potential of this article</h3><div>As a bulk endocytic process, macropinocytosis offers a novel therapeutic target for bone-related diseases. The efficacy of EIPA in suppressing osteoclastogenesis and bone resorption suggests its potential as a clinical intervention drug.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 267-279"},"PeriodicalIF":5.9,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145220805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histone modifications: Unveiling the epigenetic enigma of degenerative skeletal diseases 组蛋白修饰:揭示退行性骨骼疾病的表观遗传谜团
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-20 DOI: 10.1016/j.jot.2025.08.013
Yao Zhang , Jiale Wang , Di Hua , Chunyang Fan , Wei He , Yongkang Deng , Maoting Tang , Dechun Geng , Xiexing Wu , Haiqing Mao
Degenerative skeletal diseases, including osteoporosis, osteoarthritis, and intervertebral disc degeneration, are prevalent age-related conditions characterized by progressive tissue degeneration and functional decline. Histone modifications are covalent modifications of histone residues, catalyzed by specific enzymes, that modulate chromatin architecture and transcriptional activity. Accumulating evidence highlights the critical involvement of histone modifications in orchestrating disease-associated transcriptional programs. In osteoporosis, histone modifications regulate osteoblast and osteoclast differentiation, thereby disrupting bone homeostasis. In osteoarthritis, they drive the expression of matrix-degrading enzymes in chondrocytes, contributing to cartilage degradation. In intervertebral disc degeneration, they are implicated in nucleus pulposus cell senescence, apoptosis, and extracellular matrix degradation. This review summarizes the distinct mechanistic roles of histone modifications across these conditions and explores the therapeutic potential of targeting histone-modifying enzymes, underscoring epigenetic regulation as a promising strategy for precision intervention in degenerative skeletal diseases.
The translational potential of this article: This review comprehensively explores the role of histone modifications in degenerative skeletal diseases and evaluates the potential of histone-modifying enzyme inhibitors as therapeutic targets. These insights provide new strategies and directions for the treatment of degenerative skeletal diseases.
退行性骨骼疾病,包括骨质疏松症、骨关节炎和椎间盘退变,是常见的与年龄相关的疾病,其特征是进行性组织变性和功能下降。组蛋白修饰是组蛋白残基共价修饰,由特定酶催化,可调节染色质结构和转录活性。越来越多的证据强调了组蛋白修饰在协调疾病相关转录程序中的关键作用。在骨质疏松症中,组蛋白修饰调节成骨细胞和破骨细胞的分化,从而破坏骨稳态。在骨关节炎中,它们驱动软骨细胞中基质降解酶的表达,促进软骨降解。在椎间盘退变中,它们与髓核细胞衰老、细胞凋亡和细胞外基质降解有关。这篇综述总结了组蛋白修饰在这些疾病中的独特机制作用,并探讨了靶向组蛋白修饰酶的治疗潜力,强调表观遗传调控是精确干预退行性骨骼疾病的一种有前途的策略。本文的翻译潜力:本文全面探讨了组蛋白修饰在退行性骨骼疾病中的作用,并评估了组蛋白修饰酶抑制剂作为治疗靶点的潜力。这些见解为退行性骨骼疾病的治疗提供了新的策略和方向。
{"title":"Histone modifications: Unveiling the epigenetic enigma of degenerative skeletal diseases","authors":"Yao Zhang ,&nbsp;Jiale Wang ,&nbsp;Di Hua ,&nbsp;Chunyang Fan ,&nbsp;Wei He ,&nbsp;Yongkang Deng ,&nbsp;Maoting Tang ,&nbsp;Dechun Geng ,&nbsp;Xiexing Wu ,&nbsp;Haiqing Mao","doi":"10.1016/j.jot.2025.08.013","DOIUrl":"10.1016/j.jot.2025.08.013","url":null,"abstract":"<div><div>Degenerative skeletal diseases, including osteoporosis, osteoarthritis, and intervertebral disc degeneration, are prevalent age-related conditions characterized by progressive tissue degeneration and functional decline. Histone modifications are covalent modifications of histone residues, catalyzed by specific enzymes, that modulate chromatin architecture and transcriptional activity. Accumulating evidence highlights the critical involvement of histone modifications in orchestrating disease-associated transcriptional programs. In osteoporosis, histone modifications regulate osteoblast and osteoclast differentiation, thereby disrupting bone homeostasis. In osteoarthritis, they drive the expression of matrix-degrading enzymes in chondrocytes, contributing to cartilage degradation. In intervertebral disc degeneration, they are implicated in nucleus pulposus cell senescence, apoptosis, and extracellular matrix degradation. This review summarizes the distinct mechanistic roles of histone modifications across these conditions and explores the therapeutic potential of targeting histone-modifying enzymes, underscoring epigenetic regulation as a promising strategy for precision intervention in degenerative skeletal diseases.</div><div>The translational potential of this article: This review comprehensively explores the role of histone modifications in degenerative skeletal diseases and evaluates the potential of histone-modifying enzyme inhibitors as therapeutic targets. These insights provide new strategies and directions for the treatment of degenerative skeletal diseases.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 245-266"},"PeriodicalIF":5.9,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145096426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An aptamer specifically targeting mCRP ameliorates experimental arthritis 特异性靶向mCRP的适体可改善实验性关节炎
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-17 DOI: 10.1016/j.jot.2025.08.010
Zhuqian Wang , Duoli Xie , Peixi Zhu , Jianmin Guo , Chunhao Cao , Yu Du , Aiping Lu , Chao Liang

Background

Recent evidence highlights the important role of the liver–bone axis in the development of arthritis, particularly rheumatoid arthritis (RA) and osteoarthritis (OA). The liver secretes various factors that impact joint health, one of which is C-reactive protein (CRP), elevated in RA and OA patients. Traditionally regarded as an inflammatory marker, the causal role of CRP in arthritis development remains a topic of debate due to the existence of its two isoforms with opposing functions: native pentameric CRP (nCRP) and monomeric CRP (mCRP).

Methods

We generated hepatocyte-specific CRP knockout mice to investigate the causal role of CRP in RA and OA mouse models. In vitro experiments were conducted to assess the effects of mCRP and nCRP on phenotypic changes in effector cells common to RA and OA, including fibroblast-like synoviocytes (FLSs), monocytes/macrophages, and chondrocytes. Using systematic evolution of ligands by exponential enrichment (SELEX), we screened nucleic acid aptamers targeting mCRP rather than nCRP. We determined the neutralizing effects of the selected aptamers on mCRP in vitro and explored their therapeutic potential and safety in RA and OA mouse models.

Results

Hepatocyte-specific knockout of CRP significantly reduced disease severity in RA and OA mouse models. mCRP promoted in vitro pathological changes in FLSs, monocytes/macrophages, and chondrocytes, while nCRP exhibited minimal or slightly protective effects. We identified an aptamer, ApmCRP3, which effectively inhibited mCRP-induced pathological changes of RA and OA effector cells in vitro. In mouse models of RA and OA, ApmCRP3 displayed strong therapeutic effects and a favorable safety profile.

Conclusion

This study identifies hepatocyte-derived mCRP as a contributor to RA and OA pathogenesis and highlights ApmCRP3 aptamer as a promising therapeutic candidate.

The translational potential of this article

This study highlights the therapeutic potential of ApmCRP3 in attenuating mCRP-driven pathology and controlling arthritis progression.
最近的证据强调肝-骨轴在关节炎,特别是类风湿性关节炎(RA)和骨关节炎(OA)的发展中的重要作用。肝脏分泌各种影响关节健康的因子,其中之一是c反应蛋白(CRP),在RA和OA患者中升高。传统上被认为是一种炎症标志物,CRP在关节炎发展中的因果作用仍然是一个有争议的话题,因为它存在两种功能相反的亚型:天然五聚体CRP (nCRP)和单体CRP (mCRP)。方法制备肝细胞特异性CRP敲除小鼠,研究CRP在RA和OA小鼠模型中的因果作用。体外实验评估mCRP和nCRP对RA和OA常见的效应细胞(包括成纤维细胞样滑膜细胞(FLSs)、单核/巨噬细胞和软骨细胞)表型变化的影响。利用指数富集配体的系统进化(SELEX),我们筛选了靶向mCRP而非nCRP的核酸适体。我们在体外测定了所选适配体对mCRP的中和作用,并探讨了它们在RA和OA小鼠模型中的治疗潜力和安全性。结果造血细胞特异性敲除CRP可显著降低RA和OA小鼠模型的疾病严重程度。mCRP促进了FLSs、单核/巨噬细胞和软骨细胞的体外病理改变,而nCRP表现出最小或轻微的保护作用。我们在体外鉴定出一种适体ApmCRP3,它能有效抑制mcrp诱导的RA和OA效应细胞的病理变化。在RA和OA小鼠模型中,ApmCRP3显示出强大的治疗效果和良好的安全性。结论本研究确定肝细胞源性mCRP参与RA和OA发病机制,并强调ApmCRP3适体是一种有前景的治疗候选体。本研究强调了ApmCRP3在减轻mcrp驱动的病理和控制关节炎进展方面的治疗潜力。
{"title":"An aptamer specifically targeting mCRP ameliorates experimental arthritis","authors":"Zhuqian Wang ,&nbsp;Duoli Xie ,&nbsp;Peixi Zhu ,&nbsp;Jianmin Guo ,&nbsp;Chunhao Cao ,&nbsp;Yu Du ,&nbsp;Aiping Lu ,&nbsp;Chao Liang","doi":"10.1016/j.jot.2025.08.010","DOIUrl":"10.1016/j.jot.2025.08.010","url":null,"abstract":"<div><h3>Background</h3><div>Recent evidence highlights the important role of the liver–bone axis in the development of arthritis, particularly rheumatoid arthritis (RA) and osteoarthritis (OA). The liver secretes various factors that impact joint health, one of which is C-reactive protein (CRP), elevated in RA and OA patients. Traditionally regarded as an inflammatory marker, the causal role of CRP in arthritis development remains a topic of debate due to the existence of its two isoforms with opposing functions: native pentameric CRP (nCRP) and monomeric CRP (mCRP).</div></div><div><h3>Methods</h3><div>We generated hepatocyte-specific CRP knockout mice to investigate the causal role of CRP in RA and OA mouse models. <em>In vitro</em> experiments were conducted to assess the effects of mCRP and nCRP on phenotypic changes in effector cells common to RA and OA, including fibroblast-like synoviocytes (FLSs), monocytes/macrophages, and chondrocytes. Using systematic evolution of ligands by exponential enrichment (SELEX), we screened nucleic acid aptamers targeting mCRP rather than nCRP. We determined the neutralizing effects of the selected aptamers on mCRP <em>in vitro</em> and explored their therapeutic potential and safety in RA and OA mouse models.</div></div><div><h3>Results</h3><div>Hepatocyte-specific knockout of CRP significantly reduced disease severity in RA and OA mouse models. mCRP promoted <em>in vitro</em> pathological changes in FLSs, monocytes/macrophages, and chondrocytes, while nCRP exhibited minimal or slightly protective effects. We identified an aptamer, ApmCRP3, which effectively inhibited mCRP-induced pathological changes of RA and OA effector cells <em>in vitro</em>. In mouse models of RA and OA, ApmCRP3 displayed strong therapeutic effects and a favorable safety profile.</div></div><div><h3>Conclusion</h3><div>This study identifies hepatocyte-derived mCRP as a contributor to RA and OA pathogenesis and highlights ApmCRP3 aptamer as a promising therapeutic candidate.</div></div><div><h3>The translational potential of this article</h3><div>This study highlights the therapeutic potential of ApmCRP3 in attenuating mCRP-driven pathology and controlling arthritis progression.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 228-244"},"PeriodicalIF":5.9,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145096427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced bioactive materials and strategies for tendon repair and function restoration 用于肌腱修复和功能恢复的先进生物活性材料和策略
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-15 DOI: 10.1016/j.jot.2025.08.012
Sidan Wang , Zixuan Ou , Feng Xiao , Xiaobo Feng , Lei Tan , Shuangshuang Cheng , Di Wu , Cao Yang , Haoqun Yao
Tendon injury is one of the most common clinical challenges in musculoskeletal disorders. Effective tendon repair is crucial for restoring patients' motor function and improving their quality of life. Recent advances in bioactive material-mediated tendon regeneration have shown great therapeutic potential and clinical relevance. However, systematic reviews that comprehensively integrate these developments are still scarce. Firstly, this article presents the selection of bioactive components, mainly including cell-based therapeutic strategies and nanodrug delivery strategies. Secondly, bioactive materials delivery system using tissue-engineered scaffolds is discussed in detail. In this section, we discuss the efficacy of scaffolds in tendon repair through different scaffold preparation methods and synthetic raw materials. Furthermore, the application of hydrogel systems such as enhanced hydrogels, bioadhesive hydrogels and multifunctional hydrogels in tendon repair strategies is systematically and comprehensively presented. Finally, based on a detailed review of the field, current challenges in the field were proposed and potential research directions in the field were identified, including potential research directions in smart bioactive materials and personalized treatment strategies.

The translational potential of this article

This review synthesizes tendon regeneration strategies—from molecular mechanisms to tissue-level integration—including bioactive component selection and delivery systems using tissue-engineered scaffolds. It identifies translational barriers and proposes new strategies in tendon-specific safety validation, scalable manufacturing uniformity and cost-effectiveness versus conventional therapies. These insights will refine clinical strategies for tendon injuries and advance targeted bioactive biomaterials for localized regeneration.
肌腱损伤是肌肉骨骼疾病中最常见的临床挑战之一。有效的肌腱修复对于恢复患者的运动功能和改善患者的生活质量至关重要。生物活性材料介导的肌腱再生的最新进展显示出巨大的治疗潜力和临床意义。然而,全面整合这些发展的系统综述仍然很少。本文首先介绍了生物活性成分的选择,主要包括基于细胞的治疗策略和纳米给药策略。其次,详细讨论了基于组织工程支架的生物活性材料递送系统。在本节中,我们通过不同的支架制备方法和合成原料来讨论支架在肌腱修复中的功效。此外,系统、全面地介绍了增强型水凝胶、生物黏附型水凝胶和多功能水凝胶等水凝胶体系在肌腱修复策略中的应用。最后,在详细回顾该领域的基础上,提出了该领域当前面临的挑战,并确定了该领域潜在的研究方向,包括智能生物活性材料的潜在研究方向和个性化治疗策略。本文综述了肌腱再生策略,从分子机制到组织水平的整合,包括生物活性成分的选择和使用组织工程支架的递送系统。它确定了转化障碍,并提出了针对肌腱特异性安全性验证、可扩展制造一致性和与传统疗法相比的成本效益的新策略。这些见解将完善肌腱损伤的临床策略,并推进靶向生物活性生物材料的局部再生。
{"title":"Advanced bioactive materials and strategies for tendon repair and function restoration","authors":"Sidan Wang ,&nbsp;Zixuan Ou ,&nbsp;Feng Xiao ,&nbsp;Xiaobo Feng ,&nbsp;Lei Tan ,&nbsp;Shuangshuang Cheng ,&nbsp;Di Wu ,&nbsp;Cao Yang ,&nbsp;Haoqun Yao","doi":"10.1016/j.jot.2025.08.012","DOIUrl":"10.1016/j.jot.2025.08.012","url":null,"abstract":"<div><div>Tendon injury is one of the most common clinical challenges in musculoskeletal disorders. Effective tendon repair is crucial for restoring patients' motor function and improving their quality of life. Recent advances in bioactive material-mediated tendon regeneration have shown great therapeutic potential and clinical relevance. However, systematic reviews that comprehensively integrate these developments are still scarce. Firstly, this article presents the selection of bioactive components, mainly including cell-based therapeutic strategies and nanodrug delivery strategies. Secondly, bioactive materials delivery system using tissue-engineered scaffolds is discussed in detail. In this section, we discuss the efficacy of scaffolds in tendon repair through different scaffold preparation methods and synthetic raw materials. Furthermore, the application of hydrogel systems such as enhanced hydrogels, bioadhesive hydrogels and multifunctional hydrogels in tendon repair strategies is systematically and comprehensively presented. Finally, based on a detailed review of the field, current challenges in the field were proposed and potential research directions in the field were identified, including potential research directions in smart bioactive materials and personalized treatment strategies.</div></div><div><h3>The translational potential of this article</h3><div>This review synthesizes tendon regeneration strategies—from molecular mechanisms to tissue-level integration—including bioactive component selection and delivery systems using tissue-engineered scaffolds. It identifies translational barriers and proposes new strategies in tendon-specific safety validation, scalable manufacturing uniformity and cost-effectiveness versus conventional therapies. These insights will refine clinical strategies for tendon injuries and advance targeted bioactive biomaterials for localized regeneration.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 204-227"},"PeriodicalIF":5.9,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145060059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and multi-center validation of a software program, Ofeye 3.0, for automated all-inclusive vertebral fracture detection with chest/abdominal CT images Ofeye 3.0软件程序的开发和多中心验证,用于通过胸部/腹部CT图像自动进行全方位椎体骨折检测
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-13 DOI: 10.1016/j.jot.2025.08.011
Ben-Heng Xiao , Zhen-Hua Gao , Cai-Ying Li , Xiao-Ming Leng , Er-Zhu Du , Jian-Bing Ma , Fu-Shan Liu , Jing-Shan Gong , Zhi-Guo Ju , Ming-Yuan Yuan , Hui-Ming Zhu , Michael S.Y. Zhu , Timothy YC. Kwok , Yì Xiáng J. Wáng

Background

Missing report for fragility vertebral fracture (VF) on chest/abdominal CT is common when the indication is not spine disorders. This represents a missed opportunity to alert patients to take preventive measures to improve bone health and prevent further severe fractures. In this study, we aim to develop a software program for automated detection of VF with existing chest/abdominal CT scans and validate its detection performance.

Methods

An automated sagittal Central Slab reconstruction (CSR) method for CT axial images was developed. For reference VF reading, VFs inclusive of those of with <20 % vertebral height loss and those of endplate fracture with minimal vertebral height loss were identified. VFs were also differentiated from osteoarthritic wedging and endplatitis short vertebrae. Prior knowledge of VF detection models for lateral radiograph were transferred to a new ‘Ofeye 3.0’ model optimized for VF detection on CT image. Training CT images were obtained from nine centers, totaling 3313 cases without VF and 835 cases with VF. For external validation, CT images were from five centers totaling 732 cases without VF and 224 cases with VF.

Results

The automated CSR method showed advantages in demonstrating structural changes of the endplate and adjacent structures. For detecting VF in chest/abdominal CT scans, counting case-by-case and compared with the reference reading, the average performance of Ofeye 3.0 was accuracy 0.967, sensitivity 0.906, and specificity 0.986. Most of false negative or false positive cases were minimal or mild VF, or with image artifacts, or with VF close to the peripheral of CSR images.

Conclusions

Despite the challenging requirements for the software to detect all-inclusive VF, our results compare favorably with other published automated VF detection models.

The translational potential of this article

We developed a software program for automated all-inclusive VF detection on chest and/or abdominal CT image data and conducted a multi-center external validation study. This software is proved to have high VF detection precision. By alerting patients of the VFs likely related to osteoporosis and in turn the patients taking measures to prevent further fracture, the integration of this software into radiological practice will improve patient outcomes and reduce healthcare costs.
背景:当适应症不是脊柱疾病时,胸腹CT上脆性椎体骨折(VF)的缺失报告很常见。这意味着错过了提醒患者采取预防措施以改善骨骼健康和防止进一步严重骨折的机会。在这项研究中,我们的目标是开发一个软件程序来自动检测VF与现有的胸部/腹部CT扫描,并验证其检测性能。方法建立CT轴向图像自动矢状中央板重建(CSR)方法。作为参考VF读数,确定VF包括椎体高度损失20%的VF和椎体高度损失最小的终板骨折VF。VFs也可与骨关节炎楔入性和短椎骨内炎区分。将侧位x线片VF检测模型的先验知识转移到新的“Ofeye 3.0”模型中,该模型针对CT图像的VF检测进行了优化。从9个中心获得训练CT图像,无VF 3313例,有VF 835例。为了进行外部验证,CT图像来自5个中心,共732例无VF和224例有VF。结果自动CSR方法在显示终板及邻近结构的结构变化方面具有优势。对于胸/腹CT扫描中VF的检测,逐例计数并与参考读数比较,Ofeye 3.0的平均表现为准确率0.967,灵敏度0.906,特异性0.986。大多数假阴性或假阳性病例是轻微或轻微的VF,或有图像伪影,或VF靠近CSR图像的外围。尽管对软件检测全面VF的要求具有挑战性,但我们的结果与其他已发表的自动VF检测模型相比具有优势。我们开发了一个软件程序,用于自动检测胸部和/或腹部CT图像数据的全方位VF,并进行了多中心外部验证研究。实验证明该软件具有较高的VF检测精度。通过提醒患者可能与骨质疏松症相关的VFs,从而使患者采取措施防止进一步骨折,将该软件集成到放射实践中将改善患者的治疗效果并降低医疗成本。
{"title":"Development and multi-center validation of a software program, Ofeye 3.0, for automated all-inclusive vertebral fracture detection with chest/abdominal CT images","authors":"Ben-Heng Xiao ,&nbsp;Zhen-Hua Gao ,&nbsp;Cai-Ying Li ,&nbsp;Xiao-Ming Leng ,&nbsp;Er-Zhu Du ,&nbsp;Jian-Bing Ma ,&nbsp;Fu-Shan Liu ,&nbsp;Jing-Shan Gong ,&nbsp;Zhi-Guo Ju ,&nbsp;Ming-Yuan Yuan ,&nbsp;Hui-Ming Zhu ,&nbsp;Michael S.Y. Zhu ,&nbsp;Timothy YC. Kwok ,&nbsp;Yì Xiáng J. Wáng","doi":"10.1016/j.jot.2025.08.011","DOIUrl":"10.1016/j.jot.2025.08.011","url":null,"abstract":"<div><h3>Background</h3><div>Missing report for fragility vertebral fracture (VF) on chest/abdominal CT is common when the indication is not spine disorders. This represents a missed opportunity to alert patients to take preventive measures to improve bone health and prevent further severe fractures. In this study, we aim to develop a software program for automated detection of VF with existing chest/abdominal CT scans and validate its detection performance.</div></div><div><h3>Methods</h3><div>An automated sagittal Central Slab reconstruction (CSR) method for CT axial images was developed. For reference VF reading<em>,</em> VFs inclusive of those of with &lt;20 % vertebral height loss and those of endplate fracture with minimal vertebral height loss were identified. VFs were also differentiated from osteoarthritic wedging and endplatitis short vertebrae. Prior knowledge of VF detection models for lateral radiograph were transferred to a new ‘Ofeye 3.0’ model optimized for VF detection on CT image. Training CT images were obtained from nine centers, totaling 3313 cases without VF and 835 cases with VF. For external validation, CT images were from five centers totaling 732 cases without VF and 224 cases with VF.</div></div><div><h3>Results</h3><div>The automated CSR method showed advantages in demonstrating structural changes of the endplate and adjacent structures. For detecting VF in chest/abdominal CT scans, counting case-by-case and compared with the reference reading, the average performance of Ofeye 3.0 was accuracy 0.967, sensitivity 0.906, and specificity 0.986. Most of false negative or false positive cases were minimal or mild VF, or with image artifacts, or with VF close to the peripheral of CSR images.</div></div><div><h3>Conclusions</h3><div>Despite the challenging requirements for the software to detect all-inclusive VF, our results compare favorably with other published automated VF detection models.</div></div><div><h3>The translational potential of this article</h3><div>We developed a software program for automated all-inclusive VF detection on chest and/or abdominal CT image data and conducted a multi-center external validation study. This software is proved to have high VF detection precision. By alerting patients of the VFs likely related to osteoporosis and in turn the patients taking measures to prevent further fracture, the integration of this software into radiological practice will improve patient outcomes and reduce healthcare costs.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 192-203"},"PeriodicalIF":5.9,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145045683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-scale biomimetic fusion construction of cerium ion hydrogel-scaffold for promoting osteoporotic bone defect repair 多尺度仿生融合构建促进骨质疏松性骨缺损修复的铈离子水凝胶支架
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-13 DOI: 10.1016/j.jot.2025.08.015
Yesheng Jin , Shuqing Lv , Nanning Lv , Yixue Huang , Jia Wang , Yun Xiao , Xinfeng Zhou , Yanxia Ma , Gang Zhao , Fan He , Yong Xu
<div><h3>Background</h3><div>The treatment of bone defects in the context of osteoporosis encounters numerous challenges. In the osteoporotic microenvironment, bone resorption outweighs bone formation, impeding the self-repair of bone defect areas. Furthermore, the deterioration of osteogenesis-angiogenesis coupling function at the defect sites and excessive inflammatory responses further complicate the treatment of bone defects. Hence, an improved approach is urgently needed to enhance the treatment of osteoporotic bone defects.</div></div><div><h3>Methods</h3><div>Our efficient strategy has developed a multi-scale biomimetic fusion alendronate sodium cerium ion hydrogel scaffold, integrating 3D-printed tricalcium phosphate (TCP) scaffolds, collagen-methacrylate (COMA) hydrogel, and nanoparticles of alendronate sodium cerium ions. <em>In vitro</em>, we intervened osteoporosis rat derived bone marrow stromal cells (BMSCs) with the extract of TCP-H-Alendronate sodium cerium ion nanoparticles (ACNP) scaffold and detected the osteogenesis-related indicators through alkaline phosphatase (ALP) enzymatic activity staining, alizarin red staining, Western Blot, RT-qPCR and immunofluorescence staining to evaluate the osteogenic differentiation effect of TCP-H-ACNP scaffold. Through transcriptome sequencing, we explored the mechanism of TCP-H-ACNP scaffold affecting osteogenic differentiation of osteoporotic BMSCs. We intervened human umbilical vein endothelial cells (HUVECs) with the extract of TCP-H-ACNP scaffold and evaluated the angiogenic effect of TCP-H-ACNP scaffold through tube formation assay and cell scratch assay. <em>In vivo</em>, we established a distal femoral bone defect model in osteoporotic rats and evaluated the therapeutic effect <em>in vivo</em> through Mirco CT, Hematoxylin and Eosin (H&E) stainin, Masson staining and immunohistochemical staining.</div></div><div><h3>Results</h3><div>The results demonstrated that <em>in</em> <em>vitro</em>, TCP-H-ACNP scaffolds could promote osteogenic differentiation of osteoporotic BMSCs from rats and angiogenesis of HUVECs. <em>In vivo</em>, TCP-H-ACNP scaffolds could promote bone regeneration and repair of distal femoral bone defects in osteoporotic rats and improve local angiogenesis. Mechanistically, TCP-H-ACNP scaffolds could directly promote osteogenic differentiation of osteoporotic BMSCs from rats through the Wnt signaling pathway, and indirectly promote osteogenic differentiation by influencing Ca ion transport and improving mitochondrial function.</div></div><div><h3>Conclusion</h3><div>We create a hydrogel scaffold that not only offers adequate mechanical support but also possesses a favorable microenvironment for cell growth and contains biological factors promoting osteogenic and angiogenic differentiation.</div></div><div><h3>The translational potential of this paper</h3><div>This application represents a pioneering aspect of multi-scale biomimetic hydrogel scaffolds in addressing o
骨质疏松症的骨缺损治疗面临许多挑战。在骨质疏松微环境中,骨吸收大于骨形成,阻碍了骨缺损区域的自我修复。此外,缺损部位成骨-血管生成耦合功能的恶化和过度的炎症反应进一步使骨缺损的治疗复杂化。因此,迫切需要一种改进的方法来加强骨质疏松性骨缺损的治疗。方法将3d打印的磷酸三钙(TCP)支架、甲基丙烯酸胶原(COMA)水凝胶和阿仑膦酸钠铈离子纳米颗粒整合在一起,构建了一种多尺度仿生融合阿仑膦酸钠铈离子水凝胶支架。在体外,我们用tcp - h -阿仑膦酸钠纳米颗粒(ACNP)支架提取物干预骨质疏松大鼠骨髓基质细胞(BMSCs),通过碱性磷酸酶(ALP)酶活性染色、茜素红染色、Western Blot、RT-qPCR和免疫荧光染色检测成骨相关指标,评价TCP-H-ACNP支架的成骨分化效果。通过转录组测序,我们探讨了TCP-H-ACNP支架影响骨质疏松性骨髓间质干细胞成骨分化的机制。用TCP-H-ACNP支架提取物干预人脐静脉内皮细胞(HUVECs),通过成管实验和细胞划痕实验评价TCP-H-ACNP支架的血管生成作用。在体内,我们建立骨质疏松大鼠股骨远端骨缺损模型,通过Mirco CT、苏木精伊红(H&;E)染色、Masson染色和免疫组化染色评价体内治疗效果。结果体外实验表明,TCP-H-ACNP支架可促进骨质疏松大鼠骨髓间充质干细胞成骨分化和huvec血管生成。在体内,TCP-H-ACNP支架可促进骨质疏松大鼠股骨远端骨缺损的骨再生和修复,促进局部血管生成。机制上,TCP-H-ACNP支架可通过Wnt信号通路直接促进骨质疏松大鼠骨髓间充质干细胞成骨分化,并通过影响钙离子转运和改善线粒体功能间接促进成骨分化。结论制备的水凝胶支架不仅具有足够的机械支持,而且具有良好的细胞生长微环境,并含有促进成骨和血管分化的生物因子。这一应用代表了多尺度仿生水凝胶支架在治疗骨质疏松性骨缺损方面的一个开创性的方面,为骨质疏松性骨缺损的治疗提供了一个新的方向。
{"title":"Multi-scale biomimetic fusion construction of cerium ion hydrogel-scaffold for promoting osteoporotic bone defect repair","authors":"Yesheng Jin ,&nbsp;Shuqing Lv ,&nbsp;Nanning Lv ,&nbsp;Yixue Huang ,&nbsp;Jia Wang ,&nbsp;Yun Xiao ,&nbsp;Xinfeng Zhou ,&nbsp;Yanxia Ma ,&nbsp;Gang Zhao ,&nbsp;Fan He ,&nbsp;Yong Xu","doi":"10.1016/j.jot.2025.08.015","DOIUrl":"10.1016/j.jot.2025.08.015","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;The treatment of bone defects in the context of osteoporosis encounters numerous challenges. In the osteoporotic microenvironment, bone resorption outweighs bone formation, impeding the self-repair of bone defect areas. Furthermore, the deterioration of osteogenesis-angiogenesis coupling function at the defect sites and excessive inflammatory responses further complicate the treatment of bone defects. Hence, an improved approach is urgently needed to enhance the treatment of osteoporotic bone defects.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Our efficient strategy has developed a multi-scale biomimetic fusion alendronate sodium cerium ion hydrogel scaffold, integrating 3D-printed tricalcium phosphate (TCP) scaffolds, collagen-methacrylate (COMA) hydrogel, and nanoparticles of alendronate sodium cerium ions. &lt;em&gt;In vitro&lt;/em&gt;, we intervened osteoporosis rat derived bone marrow stromal cells (BMSCs) with the extract of TCP-H-Alendronate sodium cerium ion nanoparticles (ACNP) scaffold and detected the osteogenesis-related indicators through alkaline phosphatase (ALP) enzymatic activity staining, alizarin red staining, Western Blot, RT-qPCR and immunofluorescence staining to evaluate the osteogenic differentiation effect of TCP-H-ACNP scaffold. Through transcriptome sequencing, we explored the mechanism of TCP-H-ACNP scaffold affecting osteogenic differentiation of osteoporotic BMSCs. We intervened human umbilical vein endothelial cells (HUVECs) with the extract of TCP-H-ACNP scaffold and evaluated the angiogenic effect of TCP-H-ACNP scaffold through tube formation assay and cell scratch assay. &lt;em&gt;In vivo&lt;/em&gt;, we established a distal femoral bone defect model in osteoporotic rats and evaluated the therapeutic effect &lt;em&gt;in vivo&lt;/em&gt; through Mirco CT, Hematoxylin and Eosin (H&amp;E) stainin, Masson staining and immunohistochemical staining.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The results demonstrated that &lt;em&gt;in&lt;/em&gt; &lt;em&gt;vitro&lt;/em&gt;, TCP-H-ACNP scaffolds could promote osteogenic differentiation of osteoporotic BMSCs from rats and angiogenesis of HUVECs. &lt;em&gt;In vivo&lt;/em&gt;, TCP-H-ACNP scaffolds could promote bone regeneration and repair of distal femoral bone defects in osteoporotic rats and improve local angiogenesis. Mechanistically, TCP-H-ACNP scaffolds could directly promote osteogenic differentiation of osteoporotic BMSCs from rats through the Wnt signaling pathway, and indirectly promote osteogenic differentiation by influencing Ca ion transport and improving mitochondrial function.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;We create a hydrogel scaffold that not only offers adequate mechanical support but also possesses a favorable microenvironment for cell growth and contains biological factors promoting osteogenic and angiogenic differentiation.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;The translational potential of this paper&lt;/h3&gt;&lt;div&gt;This application represents a pioneering aspect of multi-scale biomimetic hydrogel scaffolds in addressing o","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 172-191"},"PeriodicalIF":5.9,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145045684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LOXL2 alleviates post-traumatic knee osteoarthritis and pain LOXL2减轻创伤后膝关节骨关节炎和疼痛
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-13 DOI: 10.1016/j.jot.2025.08.016
Faiza Ali , Rajnikant Dilip Raut , Chumki Choudhury , Amit Kumar Chakraborty , Cheyleann Del Valle-Ponce De Leon , Pushkar Mehra , Manish V. Bais

Background

Cartilage has limited potential for self-regeneration, and damage results in structural, molecular, and functional aberrations, leading to osteoarthritis (OA). Traumatic knee injuries can also lead to cartilage degeneration and post-traumatic OA (PTOA). This study aimed to explore whether lysyl oxidase-like 2 (LOXL2) deletion aggravate PTOA and overexpression alleviate inflammation and pain at mechanical as well as molecular levels.

Methods

Modified medial meniscectomy was performed on C57BL/6J mice knee followed by aggrecan promotes specific deletion of Loxl2 in cartilage. Transcriptomic aberrations were studied using RNA-seq and qPCR, and biomechanics and allodynia was evaluated using treadmill exhaustion and von Frey nociception test after adenovirus-delivered LOXL2 intra-articular treatment.

Results

LOXL2 was found to be downregulated in mouse knee PTOA. Loxl2 deletion in knee cartilage, shows OA-like molecular changes, and aggravates PTOA. Transcriptomics analysis revealed the upregulation of cartilage degeneration factors, signatures of inflammatory M1 macrophages, and pain. These Loxl2 deleted PTOA mice have a molecular resemblance to the human knee OA pathogenic gene signature. Interestingly, LOXL2 treatment alleviates knee joint function, reduces M1 macrophage infiltration, restores biomechanic capabilities, and reduces mechanical allodynia by relieving knee joint disability and pain.

Conclusion

LOXL2 deletion enhances the severity of PTOA, similar to human OA, whereas overexpression mitigates these effects by reducing inflammation and pain, offering LOXL2 as a therapeutic option in OA.

The translational potential of this article

LOXL2 modulates inflammation, pain, and degeneration, showing strong translational potential as a disease-modifying therapy for human PTOA.
软骨具有有限的自我再生潜力,损伤会导致结构、分子和功能失常,从而导致骨关节炎(OA)。外伤性膝关节损伤也可导致软骨变性和外伤性膝关节炎。本研究旨在探讨赖氨酸氧化酶样2 (LOXL2)缺失是否会加重PTOA,而过表达是否会在机械和分子水平上减轻炎症和疼痛。方法采用改良的C57BL/6J小鼠膝关节内侧半月板切除术,并应用聚集蛋白促进软骨中Loxl2的特异性缺失。通过RNA-seq和qPCR研究转录组畸变,通过跑步机疲劳和von Frey伤害感受试验评估腺病毒传递的LOXL2关节内治疗后的生物力学和异常性疼痛。结果发现sloxl2在小鼠膝关节pta中表达下调。膝关节软骨Loxl2缺失,表现为oa样分子改变,并加重pta。转录组学分析显示软骨变性因子上调,炎症M1巨噬细胞的特征和疼痛。这些Loxl2缺失的PTOA小鼠具有与人类膝关节OA致病基因标记的分子相似性。有趣的是,LOXL2治疗可以缓解膝关节功能,减少M1巨噬细胞浸润,恢复生物力学能力,并通过减轻膝关节残疾和疼痛来减轻机械异常性疼痛。结论LOXL2缺失增强了pta的严重程度,类似于人类OA,而过表达通过减轻炎症和疼痛来减轻这些影响,使LOXL2成为OA的治疗选择。eloxl2可调节炎症、疼痛和退行性变,显示出作为人类PTOA疾病改善疗法的强大翻译潜力。
{"title":"LOXL2 alleviates post-traumatic knee osteoarthritis and pain","authors":"Faiza Ali ,&nbsp;Rajnikant Dilip Raut ,&nbsp;Chumki Choudhury ,&nbsp;Amit Kumar Chakraborty ,&nbsp;Cheyleann Del Valle-Ponce De Leon ,&nbsp;Pushkar Mehra ,&nbsp;Manish V. Bais","doi":"10.1016/j.jot.2025.08.016","DOIUrl":"10.1016/j.jot.2025.08.016","url":null,"abstract":"<div><h3>Background</h3><div>Cartilage has limited potential for self-regeneration, and damage results in structural, molecular, and functional aberrations, leading to osteoarthritis (OA). Traumatic knee injuries can also lead to cartilage degeneration and post-traumatic OA (PTOA). This study aimed to explore whether lysyl oxidase-like 2 (LOXL2) deletion aggravate PTOA and overexpression alleviate inflammation and pain at mechanical as well as molecular levels.</div></div><div><h3>Methods</h3><div>Modified medial meniscectomy was performed on C57BL/6J mice knee followed by aggrecan promotes specific deletion of <em>Loxl2</em> in cartilage. Transcriptomic aberrations were studied using RNA-seq and qPCR, and biomechanics and allodynia was evaluated using treadmill exhaustion and von Frey nociception test after adenovirus-delivered LOXL2 intra-articular treatment.</div></div><div><h3>Results</h3><div>LOXL2 was found to be downregulated in mouse knee PTOA. <em>Loxl2</em> deletion in knee cartilage, shows OA-like molecular changes, and aggravates PTOA. Transcriptomics analysis revealed the upregulation of cartilage degeneration factors, signatures of inflammatory M1 macrophages, and pain. These <em>Loxl2</em> deleted PTOA mice have a molecular resemblance to the human knee OA pathogenic gene signature. Interestingly, LOXL2 treatment alleviates knee joint function, reduces M1 macrophage infiltration, restores biomechanic capabilities, and reduces mechanical allodynia by relieving knee joint disability and pain.</div></div><div><h3>Conclusion</h3><div>LOXL2 deletion enhances the severity of PTOA, similar to human OA, whereas overexpression mitigates these effects by reducing inflammation and pain, offering LOXL2 as a therapeutic option in OA.</div></div><div><h3>The translational potential of this article</h3><div>LOXL2 modulates inflammation, pain, and degeneration, showing strong translational potential as a disease-modifying therapy for human PTOA.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 159-171"},"PeriodicalIF":5.9,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145045685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropeptide Y1 receptor antagonist alleviated osteoarthritis by restoring chondrocyte autophagy through PI3K/AKT/mTOR signaling pathway 神经肽Y1受体拮抗剂通过PI3K/AKT/mTOR信号通路恢复软骨细胞自噬,减轻骨关节炎
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-12 DOI: 10.1016/j.jot.2025.08.003
Song Liu , Jianqun Wu , Yucong Lin , Haifeng Liang , Yu Cai , Le Wang , Zhao Wang , Hongxun Sang

Background

Osteoarthritis (OA) is a debilitating joint disorder affecting millions worldwide, characterized by progressive cartilage degradation and chronic pain. Emerging evidence suggests that neuropeptide Y (NPY) and its Y1 receptors are involved in OA pathogenesis, although the underlying molecular mechanisms remain poorly understood. This study investigates the role of NPY/Y1R signaling in OA progression through PI3K/AKT/mTOR-mediated regulation of chondrocyte autophagy.

Methods

Human cartilage samples were collected from ten OA patients (3 male,7 female, 63–75 years old) undergoing total knee arthroplasty and graded using the Kellgren–Lawrence system. Primary chondrocytes were isolated from neonatal C57BL/6 mice and treated with NPY (0.01–5 μM) or interleukin-1β (IL-1β, 10 ng/mL) to mimic OA-like degeneration. RNA sequencing (RNA-seq) and KEGG pathway analysis were performed to identify NPY-regulated signaling pathways. In vivo, OA was induced in 8-week-old male C57BL/6 mice via destabilization of the medial meniscus (DMM) or intra-articular injections of NPY (5 μM, every 4 weeks). Mice were treated with the Y1R antagonist (0.1 μM, weekly) or vehicle control. Pain behavior was assessed using von Frey filaments and CatWalk gait analysis. Cartilage degeneration was evaluated via histology (Safranin O/Fast Green, OARSI scoring), immunofluorescence (COLII, MMP13, LC3-II, p62), and micro-CT (subchondral bone remodeling, osteophyte formation). The activation status of the PI3K/AKT/mTOR pathway and autophagy-related markers was determined via Western blotting and immunofluorescence assays under both in vitro and in vivo conditions.

Results

NPY and Y1R expression were significantly elevated in human OA cartilage compared to normal tissue. In vitro, NPY (5 μM) suppressed chondrocyte proliferation, reduced COLII expression, and increased MMP13 production. RNA-seq revealed NPY-mediated activation of the PI3K/AKT/mTOR pathway and inhibition of autophagy-related genes. NPY treatment enhanced the phosphorylation levels of PI3K, AKT, and mTOR, while concurrently decreasing LC3II expression and increasing p62 accumulation. The Y1R antagonist reversed these effects, restoring autophagy and attenuating cartilage degradation. In vivo, NPY injections induced OA-like changes, including cartilage thinning, osteophyte formation, and mechanical allodynia. Y1R antagonist treatment mitigated these effects, improving gait parameters and reducing subchondral bone sclerosis. Immunofluorescence confirmed that Y1R inhibition decreased PI3K/AKT/mTOR signaling and enhanced autophagy in chondrocytes.

Conclusion

This study demonstrates that NPY/Y1R signaling exacerbates OA progression through PI3K/AKT/mTOR-mediated suppression of chondrocyte autophagy. Pharmacological inhibition of Y1R emerges as a novel therapeutic strategy, e
骨关节炎(OA)是一种影响全球数百万人的衰弱性关节疾病,其特征是进行性软骨退化和慢性疼痛。新的证据表明神经肽Y (NPY)及其Y1受体参与OA发病机制,尽管其潜在的分子机制尚不清楚。本研究通过PI3K/AKT/ mtor介导的软骨细胞自噬调节,探讨NPY/Y1R信号在OA进展中的作用。方法对10例OA患者(男3例,女7例,年龄63 ~ 75岁)进行全膝关节置换术,并采用Kellgren-Lawrence评分系统进行评分。从新生C57BL/6小鼠中分离原代软骨细胞,用NPY (0.01 ~ 5 μM)或白细胞介素-1β (IL-1β, 10 ng/mL)处理,模拟a样变性。通过RNA测序(RNA-seq)和KEGG通路分析鉴定npy调控的信号通路。在体内,通过破坏内侧半月板(DMM)或关节内注射NPY (5 μM,每4周),在8周龄雄性C57BL/6小鼠中诱导OA。小鼠用Y1R拮抗剂(0.1 μM,每周)或对照治疗。采用von Frey纤维和CatWalk步态分析评估疼痛行为。通过组织学(Safranin O/Fast Green, OARSI评分),免疫荧光(COLII, MMP13, LC3-II, p62)和显微ct(软骨下骨重塑,骨赘形成)评估软骨退行性变。在体外和体内条件下,通过Western blotting和免疫荧光法检测PI3K/AKT/mTOR通路和自噬相关标志物的激活状态。结果骨性关节炎软骨中snpy和Y1R的表达明显高于正常组织。在体外,NPY (5 μM)抑制软骨细胞增殖,降低COLII表达,增加MMP13的产生。RNA-seq显示npy介导的PI3K/AKT/mTOR通路的激活和自噬相关基因的抑制。NPY处理提高了PI3K、AKT和mTOR的磷酸化水平,同时降低了LC3II的表达,增加了p62的积累。Y1R拮抗剂逆转了这些作用,恢复自噬并减轻软骨降解。在体内,NPY注射诱导oa样改变,包括软骨变薄、骨赘形成和机械异常性痛。Y1R拮抗剂治疗减轻了这些影响,改善了步态参数并减少了软骨下骨硬化。免疫荧光证实,Y1R抑制降低了PI3K/AKT/mTOR信号传导,增强了软骨细胞的自噬。结论本研究表明NPY/Y1R信号通过PI3K/AKT/ mtor介导的软骨细胞自噬抑制加速OA进展。Y1R的药理抑制是一种新的治疗策略,有效地针对软骨变性和疼痛,对骨关节炎的进展具有潜在的疾病改善作用。本研究通过证明NPY Y1受体通过PI3K/AKT/mTOR通路调节软骨细胞自噬的作用,强调了NPY Y1受体作为OA的一个有希望的治疗靶点。该结果支持开发Y1R拮抗剂作为新型OA治疗药物。这项工作将分子发现与潜在的临床应用联系起来,为OA管理的变革方法提供了希望。
{"title":"Neuropeptide Y1 receptor antagonist alleviated osteoarthritis by restoring chondrocyte autophagy through PI3K/AKT/mTOR signaling pathway","authors":"Song Liu ,&nbsp;Jianqun Wu ,&nbsp;Yucong Lin ,&nbsp;Haifeng Liang ,&nbsp;Yu Cai ,&nbsp;Le Wang ,&nbsp;Zhao Wang ,&nbsp;Hongxun Sang","doi":"10.1016/j.jot.2025.08.003","DOIUrl":"10.1016/j.jot.2025.08.003","url":null,"abstract":"<div><h3>Background</h3><div>Osteoarthritis (OA) is a debilitating joint disorder affecting millions worldwide, characterized by progressive cartilage degradation and chronic pain. Emerging evidence suggests that neuropeptide Y (NPY) and its Y1 receptors are involved in OA pathogenesis, although the underlying molecular mechanisms remain poorly understood. This study investigates the role of NPY/Y1R signaling in OA progression through PI3K/AKT/mTOR-mediated regulation of chondrocyte autophagy.</div></div><div><h3>Methods</h3><div>Human cartilage samples were collected from ten OA patients (3 male,7 female, 63–75 years old) undergoing total knee arthroplasty and graded using the Kellgren–Lawrence system. Primary chondrocytes were isolated from neonatal C57BL/6 mice and treated with NPY (0.01–5 μM) or interleukin-1β (IL-1β, 10 ng/mL) to mimic OA-like degeneration. RNA sequencing (RNA-seq) and KEGG pathway analysis were performed to identify NPY-regulated signaling pathways. <em>In vivo</em>, OA was induced in 8-week-old male C57BL/6 mice via destabilization of the medial meniscus (DMM) or intra-articular injections of NPY (5 μM, every 4 weeks). Mice were treated with the Y1R antagonist (0.1 μM, weekly) or vehicle control. Pain behavior was assessed using von Frey filaments and CatWalk gait analysis. Cartilage degeneration was evaluated via histology (Safranin O/Fast Green, OARSI scoring), immunofluorescence (COLII, MMP13, LC3-II, p62), and micro-CT (subchondral bone remodeling, osteophyte formation). The activation status of the PI3K/AKT/mTOR pathway and autophagy-related markers was determined via Western blotting and immunofluorescence assays under both <em>in vitro</em> and <em>in vivo</em> conditions.</div></div><div><h3>Results</h3><div>NPY and Y1R expression were significantly elevated in human OA cartilage compared to normal tissue. <em>In vitro</em>, NPY (5 μM) suppressed chondrocyte proliferation, reduced COLII expression, and increased MMP13 production. RNA-seq revealed NPY-mediated activation of the PI3K/AKT/mTOR pathway and inhibition of autophagy-related genes. NPY treatment enhanced the phosphorylation levels of PI3K, AKT, and mTOR, while concurrently decreasing LC3II expression and increasing p62 accumulation. The Y1R antagonist reversed these effects, restoring autophagy and attenuating cartilage degradation. <em>In vivo</em>, NPY injections induced OA-like changes, including cartilage thinning, osteophyte formation, and mechanical allodynia. Y1R antagonist treatment mitigated these effects, improving gait parameters and reducing subchondral bone sclerosis. Immunofluorescence confirmed that Y1R inhibition decreased PI3K/AKT/mTOR signaling and enhanced autophagy in chondrocytes.</div></div><div><h3>Conclusion</h3><div>This study demonstrates that NPY/Y1R signaling exacerbates OA progression through PI3K/AKT/mTOR-mediated suppression of chondrocyte autophagy. Pharmacological inhibition of Y1R emerges as a novel therapeutic strategy, e","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 146-158"},"PeriodicalIF":5.9,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145045686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can alternatives to animal testing yield useful information regarding biological mechanisms and drug discovery? 动物试验的替代方案能否提供有关生物机制和药物发现的有用信息?
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-11 DOI: 10.1016/j.jot.2025.08.005
Qi Gao, Simon Kwoon-Ho Chow, Issei Shinohara, Masatoshi Murayama, Yosuke Susuki, Mayu Morita, Chao Ma, Stuart B. Goodman
Establish alternative strategies to standard animal experiments decrease animal utilization and simultaneously enhance the reliability of biological and disease models. This review highlights advancements in three areas: in vitro culture platforms, disease modeling, and in silico simulations. We first discuss the innovative in vitro approaches, including 2D coculture systems, 3D spheroids, organoids, and organ-on-chip models, which facilitate the creation of physiologically relevant environments. Then, we focus on cell selection and characterization in disease modeling, with a particular focus on bone fracture healing and inflammation. We further review the potential of in silico simulations, including molecular docking, machine learning (ML) approaches, and pharmacokinetics-pharmacodynamics (PK/PD) modeling, to predict drug efficacy, interactions, and biological outcomes. These alternative strategies provide the potential for obtaining accurate and consistent results, thereby enhancing biomedical research and decreasing dependence on animal models. The Translational Potential of this Article: This review examines in vitro organoids, microphysiological systems, and computational models as alternatives to animal testing. These methods enhance our understanding of biological mechanisms. They also reduce the requirement for animal models. Ultimately, they help accelerate drug discovery that can directly benefit patients.
建立替代标准动物实验的策略,降低动物利用率,同时提高生物和疾病模型的可靠性。这篇综述强调了三个领域的进展:体外培养平台、疾病建模和计算机模拟。我们首先讨论了创新的体外方法,包括2D共培养系统、3D球体、类器官和器官芯片模型,这些方法有助于创造生理相关环境。然后,我们专注于疾病建模中的细胞选择和表征,特别关注骨折愈合和炎症。我们进一步回顾了计算机模拟的潜力,包括分子对接、机器学习(ML)方法和药代动力学-药效学(PK/PD)建模,以预测药物疗效、相互作用和生物学结果。这些替代策略为获得准确和一致的结果提供了可能,从而加强生物医学研究并减少对动物模型的依赖。本文的转化潜力:本文综述了体外类器官、微生理系统和计算模型作为动物试验的替代品。这些方法增强了我们对生物学机制的理解。它们还减少了对动物模型的需求。最终,它们有助于加速可以直接造福患者的药物发现。
{"title":"Can alternatives to animal testing yield useful information regarding biological mechanisms and drug discovery?","authors":"Qi Gao,&nbsp;Simon Kwoon-Ho Chow,&nbsp;Issei Shinohara,&nbsp;Masatoshi Murayama,&nbsp;Yosuke Susuki,&nbsp;Mayu Morita,&nbsp;Chao Ma,&nbsp;Stuart B. Goodman","doi":"10.1016/j.jot.2025.08.005","DOIUrl":"10.1016/j.jot.2025.08.005","url":null,"abstract":"<div><div>Establish alternative strategies to standard animal experiments decrease animal utilization and simultaneously enhance the reliability of biological and disease models. This review highlights advancements in three areas: in vitro culture platforms, disease modeling, and in silico simulations. We first discuss the innovative in vitro approaches, including 2D coculture systems, 3D spheroids, organoids, and organ-on-chip models, which facilitate the creation of physiologically relevant environments. Then, we focus on cell selection and characterization in disease modeling, with a particular focus on bone fracture healing and inflammation. We further review the potential of in silico simulations, including molecular docking, machine learning (ML) approaches, and pharmacokinetics-pharmacodynamics (PK/PD) modeling, to predict drug efficacy, interactions, and biological outcomes. These alternative strategies provide the potential for obtaining accurate and consistent results, thereby enhancing biomedical research and decreasing dependence on animal models. The Translational Potential of this Article: This review examines in vitro organoids, microphysiological systems, and computational models as alternatives to animal testing. These methods enhance our understanding of biological mechanisms. They also reduce the requirement for animal models. Ultimately, they help accelerate drug discovery that can directly benefit patients.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 132-145"},"PeriodicalIF":5.9,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145045687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell RNA sequencing reveals early cell dynamics of MSC-based therapy in long bone critical-size defects in mice 单细胞RNA测序揭示了基于msc的治疗小鼠长骨临界尺寸缺陷的早期细胞动力学
IF 5.9 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-09 DOI: 10.1016/j.jot.2025.08.007
Ning Zhang , Jie Yuan , Xueping Li , Ni Su , Yiyun Wang , Shuxian Chen , Ejun Huang , Qi Gao , Fan Yang , Simon Kwoon-Ho Chow , Stuart B. Goodman
<div><h3>Background</h3><div>Bone defects resulting from various causes present significant challenges in obtaining robust bone healing. This clinical scenario is particularly difficult in cases involving large bone defects, often leading to delayed union or non-union. Autogenous bone graft is the gold standard, but it is limited by the quantity and quality of available bone. Mesenchymal stem cells (MSCs) have shown promise in enhancing bone defect healing; however, the mechanisms by which MSCs modify the local bone microenvironment and interact with other cells early in the healing process are not fully understood. Elucidating and modulating the early biological events relevant to the healing of bone defects could lead to novel therapies to obtain a more expeditious and complete outcome.</div></div><div><h3>Methods</h3><div>Critical-size femoral defects were created in 10 to 12-week-old BALB/c male mice and fixed with an external fixation device. Four weeks after the generation of the defect, secondary surgeries were performed. Mice were randomized into three groups based on the secondary surgery: Empty group - surgery was performed without implanting scaffolds or cells. Sc group - a 2 mm diameter cylindrical microribbon (μRB) scaffold was implanted into the defect site. Sc + MSC group - a scaffold embedded with MSCs was implanted into the bone defect site. One week after the secondary surgeries, the entire tissue within the bone defect site was harvested for single-cell RNA sequencing (scRNA-seq).</div></div><div><h3>Results</h3><div>Uniform manifold approximation and projection (UMAP) plots with quality filtered cells from three groups were used to identify the cell distributions in the defects. We identified thirteen populations and annotated each cluster using UMAP with Louvain clustering on combined single cells of three groups based on marker gene expression. Different cell compositions were revealed, especially the proportion of various types of immune cells in the Sc vs Sc + MSC groups. MSCs and osteoblastic lineage cells (MSC/Osteo), and osteoclasts were almost exclusively found in the Sc + MSC group. Differential gene expression and pathway analysis in major cell populations identified immune cell changes and inflammatory changes in the presence of implanted MSCs. Cell–cell communications revealed a greater number of interactions between different cell types in the Sc and Sc + MSC groups. More interactions among MSCs, macrophages, and T cells were observed in Sc + MSC groups. MSC demonstrated the highest outgoing interaction strength in all groups.</div></div><div><h3>Conclusions</h3><div>In the critical-size bone defect model, a combination of MSCs with μRB scaffolds showed an increased presence of mesenchymal lineage cells and promoted the further recruitment of macrophages and osteoclasts at 1 week. This alteration in the local immune landscape and microenvironment could enhance the cellular dynamics of critical cell populations tha
背景:各种原因导致的骨缺损对获得强健的骨愈合提出了重大挑战。这种临床情况在涉及大骨缺损的病例中尤其困难,通常导致延迟愈合或不愈合。自体骨移植是金标准,但受可用骨的数量和质量的限制。间充质干细胞(MSCs)已显示出促进骨缺损愈合的前景;然而,MSCs在愈合过程早期改变局部骨微环境并与其他细胞相互作用的机制尚不完全清楚。阐明和调节与骨缺损愈合相关的早期生物学事件可能会导致新的治疗方法,以获得更快速和完整的结果。方法采用10 ~ 12周龄BALB/c雄性小鼠建立临界大小的股骨缺损,用外固定装置固定。缺损发生4周后,进行二次手术。小鼠根据二次手术随机分为三组:空组-手术不植入支架或细胞。Sc组:在缺损部位植入直径为2mm的圆柱形微带(μRB)支架。Sc + MSC组-将MSCs包埋支架植入骨缺损部位。二次手术后一周,采集骨缺损部位内的整个组织进行单细胞RNA测序(scRNA-seq)。结果采用均匀流形逼近和投影(UMAP)图,对三组细胞进行质量过滤,识别缺陷中的细胞分布。我们鉴定了13个群体,并基于标记基因表达对三组组合单细胞使用UMAP和Louvain聚类对每个聚类进行注释。在Sc组和Sc + MSC组中发现了不同的细胞组成,特别是各种类型的免疫细胞的比例。MSC和成骨细胞谱系细胞(MSC/Osteo)以及破骨细胞几乎只存在于Sc + MSC组。主要细胞群的差异基因表达和通路分析鉴定了移植MSCs存在下的免疫细胞变化和炎症变化。细胞间通讯显示Sc和Sc + MSC组中不同细胞类型之间有更多的相互作用。在Sc + MSC组中,MSCs、巨噬细胞和T细胞之间的相互作用更多。MSC在所有组中表现出最高的外向互动强度。结论在临界尺寸骨缺损模型中,MSCs与μRB支架联合使用可增加间充质谱系细胞的存在,并促进巨噬细胞和破骨细胞的进一步募集。这种局部免疫景观和微环境的改变可以增强对成骨很重要的关键细胞群的细胞动力学。在愈合过程的早期优化这种细胞串扰可能潜在地增强基于msc的治疗方法,用于随后的临界大小骨缺损的骨再生。我们的研究结果为MSCs在支架中的局部免疫调节提供了详细的转录路线图,支持在未来临床应用中优化基于MSCs的长骨临界尺寸缺陷治疗的稳健策略。
{"title":"Single-cell RNA sequencing reveals early cell dynamics of MSC-based therapy in long bone critical-size defects in mice","authors":"Ning Zhang ,&nbsp;Jie Yuan ,&nbsp;Xueping Li ,&nbsp;Ni Su ,&nbsp;Yiyun Wang ,&nbsp;Shuxian Chen ,&nbsp;Ejun Huang ,&nbsp;Qi Gao ,&nbsp;Fan Yang ,&nbsp;Simon Kwoon-Ho Chow ,&nbsp;Stuart B. Goodman","doi":"10.1016/j.jot.2025.08.007","DOIUrl":"10.1016/j.jot.2025.08.007","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Bone defects resulting from various causes present significant challenges in obtaining robust bone healing. This clinical scenario is particularly difficult in cases involving large bone defects, often leading to delayed union or non-union. Autogenous bone graft is the gold standard, but it is limited by the quantity and quality of available bone. Mesenchymal stem cells (MSCs) have shown promise in enhancing bone defect healing; however, the mechanisms by which MSCs modify the local bone microenvironment and interact with other cells early in the healing process are not fully understood. Elucidating and modulating the early biological events relevant to the healing of bone defects could lead to novel therapies to obtain a more expeditious and complete outcome.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Critical-size femoral defects were created in 10 to 12-week-old BALB/c male mice and fixed with an external fixation device. Four weeks after the generation of the defect, secondary surgeries were performed. Mice were randomized into three groups based on the secondary surgery: Empty group - surgery was performed without implanting scaffolds or cells. Sc group - a 2 mm diameter cylindrical microribbon (μRB) scaffold was implanted into the defect site. Sc + MSC group - a scaffold embedded with MSCs was implanted into the bone defect site. One week after the secondary surgeries, the entire tissue within the bone defect site was harvested for single-cell RNA sequencing (scRNA-seq).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Uniform manifold approximation and projection (UMAP) plots with quality filtered cells from three groups were used to identify the cell distributions in the defects. We identified thirteen populations and annotated each cluster using UMAP with Louvain clustering on combined single cells of three groups based on marker gene expression. Different cell compositions were revealed, especially the proportion of various types of immune cells in the Sc vs Sc + MSC groups. MSCs and osteoblastic lineage cells (MSC/Osteo), and osteoclasts were almost exclusively found in the Sc + MSC group. Differential gene expression and pathway analysis in major cell populations identified immune cell changes and inflammatory changes in the presence of implanted MSCs. Cell–cell communications revealed a greater number of interactions between different cell types in the Sc and Sc + MSC groups. More interactions among MSCs, macrophages, and T cells were observed in Sc + MSC groups. MSC demonstrated the highest outgoing interaction strength in all groups.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;In the critical-size bone defect model, a combination of MSCs with μRB scaffolds showed an increased presence of mesenchymal lineage cells and promoted the further recruitment of macrophages and osteoclasts at 1 week. This alteration in the local immune landscape and microenvironment could enhance the cellular dynamics of critical cell populations tha","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"55 ","pages":"Pages 121-131"},"PeriodicalIF":5.9,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145019904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Orthopaedic Translation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1